CAR T-Cell Therapy Market worth $13.78 billion by 2031 | MarketsandMarkets™ Feb 16, 2026 10:15AM
Scholar Rock Appoints Jay Backstrom, M.D., M.P.H., to be its Next Chief Executive Officer Sep 20, 2022 07:00AM
LAVA Therapeutics Announces Two Appointments to its Board of Directors Jun 15, 2022 07:00AM
Pre-Open Stock Movers 11/08: (AUTL) (TTD) (BLNK) Higher; (EHTH) (BLUE) (TSLA) Lower (more...) Nov 8, 2021 08:50AM
Surge in Demand Fuels Increase of 1.6 Million Square Feet in Montgomery County, Maryland's Life Sciences Lab Inventory Jul 12, 2021 12:00PM


Nov 30, 2020 07:04AM Autolus Therapeutics (AUTL) Reports Publication of New AUTO6 Phase 1 Data in Childhood Neuroblastoma in Science Translational Medicine
Nov 30, 2020 07:00AM Autolus Therapeutics announces publication of new AUTO6 Phase 1 data in childhood neuroblastoma in Science Translational Medicine
Nov 30, 2020 07:00AM Autolus Therapeutics announces publication of new AUTO6 Phase 1 data in childhood neuroblastoma in Science Translational Medicine
Jun 17, 2020 08:00AM Novavax Announces Additions to Executive Leadership
Nov 12, 2019 04:01PM BioLife Solutions Announces Third Quarter 2019 Financial Results
Sep 16, 2019 08:00AM BioLife Solutions Announces New evo® Cold Chain Customers
Feb 25, 2019 06:25AM Vineti Reports Strategic Partnership with Autolus Therapeutics (AUTL) to Support Delivery of Novel-T Cell Therapies
Feb 25, 2019 06:15AM Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies
Feb 25, 2019 06:15AM Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies
Nov 29, 2018 06:08AM AbCellera Collaborates with Autolus on Antibody Discovery Project
Jun 27, 2018 04:00AM Citi Appointed as Depositary Bank for Autolus Therapeutics’ ADR Programme